Some studies have suggested that the MAML2 rearrangement is much more common in low-grade than high-grade MEC and that the presence of a MAML2 rearrangement identifies a biologically distinct group of MEC with a less aggressive clinical behavior [7–9]. This evidence concerns the gene MAML2 and mucoepidermoid carcinoma.